Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ocular inflammation after intraocular drug delivery: Mechanisms, risk factors, and implications for clinical practice.

Survey of ophthalmology·2026
Same author

Capsulotomy morphology in cataract surgery: comparison of five femtosecond lasers.

Journal of cataract and refractive surgery·2025
Same author

[Vascular occlusion due to isolated retinal arteriovenous malformation].

Die Ophthalmologie·2025
Same author

Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study.

Journal of translational medicine·2025
Same author

A Comparative Analysis of Carlevale IOL Versus Artisan IOL Implantation Using a Scleral Tunnel Incision Technique.

Journal of clinical medicine·2024
Same author

Correspondence.

Retina (Philadelphia, Pa.)·2024

Related Experiment Video

Updated: May 17, 2026

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Vitreous traction after Ozurdex injection

Christoph R Clemens, Thomas Bertelmann, Carsten H Meyer

    Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
    |October 27, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
    07:13

    An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

    Published on: December 7, 2016

    Related Experiment Videos

    Last Updated: May 17, 2026

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
    04:36

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

    Published on: April 14, 2026

    An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
    07:13

    An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

    Published on: December 7, 2016